AB Science S.A. (EPA:AB)
0.9480
+0.0180 (1.94%)
Jun 3, 2026, 5:35 PM CET
AB Science Revenue
In the year 2025, AB Science had annual revenue of 1.17M EUR with 9.51% growth. AB Science had revenue of 659.00K in the half year ending December 31, 2025, with 26.25% growth.
Revenue
1.17M
Revenue Growth
+9.51%
P/S Ratio
61.80
Revenue / Employee
32.61K
Employees
36
Market Cap
72.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.17M | 102.00K | 9.51% |
| Dec 31, 2024 | 1.07M | 102.00K | 10.52% |
| Dec 31, 2023 | 970.00K | 12.00K | 1.25% |
| Dec 31, 2022 | 958.00K | -649.00K | -40.39% |
| Dec 31, 2021 | 1.61M | 24.00K | 1.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 47.35B |
| EssilorLuxottica Société anonyme | 28.49B |
| Ipsen | 3.93B |
| Sartorius Stedim Biotech | 2.98B |
| Eurofins-Cerep | 41.10M |
| Klea Holding | 22.17M |
| ABL Diagnostics Société anonyme | 8.22M |
| ABIONYX Pharma | 4.06M |
AB Science News
- 1 day ago - AB Science : Stonegate Capital Partners updates its coverage of AB Science's stock with a target price of EUR 4.25 per share - GlobeNewsWire
- 9 days ago - AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share - GlobeNewsWire
- 21 days ago - AB Science reports its revenues for the year 2025 and provides an update on its activities - GlobeNewsWire
- 21 days ago - AB Science Earnings release: H2 2025 - Filings
- 5 weeks ago - AB Science announces the successful completion of a EUR 3.2 million private placement - GlobeNewsWire
- 5 weeks ago - AB Science announces a final agreement on the renegotiation of the repayment terms of its loans with all of its financial creditors - GlobeNewsWire
- 6 weeks ago - AB Science: New publication on medrxiv demonstrating substantial survival benefits and preserved quality of life with masitinib in ALS patients - GlobeNewsWire
- 6 weeks ago - AB Science provides an update on its clinical development program. - GlobeNewsWire